Volume 5, Issue 3 (12-2015)                   cmja 2015, 5(3): 1248-1257 | Back to browse issues page

XML Persian Abstract Print


1- Faculty of Nursing and Midwifery, Mashhad University of Medical Sciences, Mashhad, Iran,zarifnejadgh@mums.ac.ir
2- Mashhad University of Medical Sciences , eshghie901@mums.ac.ir
3- Mashhad University of Medical Sciences
Abstract:   (7058 Views)

Introduction: Most patients receiving Nitroglycerine infusion, experience some degree of headache. This study is conducted to investigate the effect of aromatherapy with Lavender essential oil in treatment of headache due to Nitroglycerine infusion in patient admitted to cardiac emergency department.

Methods: This clinical trial was done on 135 patients with informed consent. They were randomly allocated in tree groups of 45 participants (Lavender essential oil, Acetaminophen tablet and placebo). In Lavender essential oil group, subjects inhaled Lavender essential oil and in placebo group, liquid Paraffin in a cotton filled by 3 drops of the product for 30 minute. In the Acetaminophen group, one 325 mg tablet was used. The intensity of headache was measured by visual analogue scale before and, 15, 30 and 60 minutes after intervention. Data analysis was done using Chi-square, Kruskal-Wallis, Man-Whitney U, Friedman and Wilcoxon tests.

Findings: Findings showed that there was a significant difference between headache intensity in the three groups after intervention (p=0.001). Two by two comparison between groups showed that the decrease in headache was significant in Lavender essential oil group compared to Acetaminophen group (p=0.001). Also the decrease was significant in Acetaminophen group compared to placebo group (p=0.001).

Conclusion: Lavender essential oil aromatherapy can be effective in reducing headache in patients receiving Nitroglycerine infusion. Further research is recommended in this area.

Full-Text [PDF 154 kb]   (2758 Downloads)    
Type of Study: Research |

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.